Formosa Pharmaceuticals Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Erick Co
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.1yrs |
| CEO ownership | n/a |
| Management average tenure | 1.1yrs |
| Board average tenure | no data |
Recent management updates
Recent updates
CEO
Erick Co
2.1yrs
Tenure
Dr. Erick Co, Ph D., serves as Director of New Drug Development at ScinoPharm Taiwan, Ltd. Dr. Co serves as the Chief Executive Officer of Formosa Pharmaceuticals, Inc. and has been its President since 202...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & CEO | 2.1yrs | no data | no data | |
| Director of Finance & CFO | less than a year | no data | no data | |
| Manager of Legal & Corporate Communications | 1.1yrs | no data | no data | |
| Chief Business & Strategy Officer | 1.1yrs | no data | 0.023% NT$ 1.2m |
1.1yrs
Average Tenure
Experienced Management: 6838's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/01 02:42 |
| End of Day Share Price | 2025/01/22 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Formosa Pharmaceuticals, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|